Moore Capital Management’s Organogenesis Holdings ORGO Stock Holding History

Moore Capital Management’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,290,000	Closed	-$13.1M	–	291
2018 Q3	$13.1M	Hold	1,290,000	–	–	0.28%	66
2018 Q2	$12.9M	Sell	1,290,000 -100,000	-7%	-$1M	0.32%	77
2018 Q1	$13.9M	Sell	1,390,000 -100,000	-7%	-$996K	0.28%	90
2017 Q4	$14.8M	Hold	1,490,000	–	–	0.27%	93
2017 Q3	$14.9M	Hold	1,490,000	–	–	0.29%	89
2017 Q2	$14.7M	Hold	1,490,000	–	–	0.45%	71
2017 Q1	$14.8M	Buy	+1,490,000	New	+$14.7M	0.4%	68

Moore Capital Management's ORGO Position: Q4 2018 in Review

Moore Capital Management sold out of Organogenesis Holdings (ORGO) in Q4 2018, closing a stake of 1,290,000 shares — an estimated $13.1M sold.

Moore Capital Management first reported a position in ORGO in Q1 2017 and held it in 7 quarters. The position peaked at $14.9M in Q3 2017. 0 funds tracked by Wall St. Rank hold ORGO as of Q4 2018.

Moore Capital Management reported no remaining Organogenesis Holdings position as of Q4 2018 after selling out during the quarter.
Moore Capital Management sold 1,290,000 Organogenesis Holdings shares in Q4 2018, an estimated $13.1M.
Moore Capital Management first reported a position in Organogenesis Holdings in Q1 2017 and held it in 7 quarters.
Moore Capital Management's Organogenesis Holdings position peaked at $14.9M in Q3 2017.
0 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2018.

Based on Moore Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.